Tin tức & Cập nhật

Treatment with apremilast results in fat mass reduction among patients with psoriatic arthritis (PsA), indicating positive cardiovascular (CV) and metabolic effects, which may lower the risk of CV events, a recent study has shown.

Significant delays occur in the initiation of tocilizumab (TCZ) therapy among patients with giant cell arteritis (GCA), reports a US study.

New drug applications approved by US FDA as of 1-15 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Updated results from the phase IIIB HARMONIE trial demonstrate sustained efficacy of the long-acting monoclonal antibody nirsevimab against respiratory syncytial virus-associated lower respiratory tract infection (RSV-LRTI) hospitalization through day 181 post-dose.

Infants who contract an invasive bacterial infection during the first week of life have double the risk of epilepsy in childhood, according to a register-based cohort study from Denmark.

The addition of once-weekly semaglutide to an automated insulin delivery (AID) system leads to significantly improved time in range (TIR) and reduced body weight in adults with type 1 diabetes (T1D) and obesity compared with AID alone, according to the ADJUST-T1D* trial presented at ADA 2025. 

Viên nang cứng taurin + cao khô lá Bạch quả (Ginkgo biloba) 

Viên nén bao phim 10 mg/10 mg hoặc 20 mg/10 mg rosuvastatin + ezetimib

New drug applications approved by US FDA as of 16-30 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.